Holland & Knight's Public Policy & Regulation Group is proud to partner with the Rare Disease Diversity Coalition (RDDC) for a three-part podcast series highlighting diverse perspectives on genetic testing and kidney disease. RDDC brings together health and diversity advocates, rare disease specialists and industry leaders to identify and advocate for evidenced-based solutions to alleviate the disproportionate burden of rare diseases on communities of color. This series, co-hosted by Senior Policy Advisor Shawna Watley and Advocacy Relations Professional and RDCC Consultant Deanna Darlington, lifts up important voices from the field and educates listeners about the experiences of those living with rare diseases. Special thanks to Vertex Pharmaceuticals and Travere Therapeutics for their sponsorship and support of this podcast. In this episode, our co-hosts are joined by Dr. Tralonda Triplett, Director of Operations for the Institute for Successful Leadership, and Pamela Price, Deputy Director for The Balm in Gilead. This conversation centers around health equity and its complexities. Health equity, as defined by the Center for Disease Control and Prevention (CDC), is when every person has the opportunity to attain his or her full potential when it comes to health, and no one is disadvantaged from achieving this potential because of social position or other socially determined circumstances. The group dives deep on this definition and explains why equitable healthcare is so important in communities worldwide. Dr. Triplett and Ms. Price each share how their organizations are working toward equity in healthcare, one bite at a time, and how improving health equity requires a collective effort across systems. They also offer specific insight on ways healthcare organizations can create and support equity in the community. Rare Disease Diversity Coalition: https://www.rarediseasediversity.org/ For more, visit: https://www.hklaw.com/en/insights/media-entities/2022/12/podcast-achieving-health-equity-one-bite-at-a-time